David Colleran

2021

In 2021, David Colleran earned a total compensation of $1.4M as EVP, General Counsel and Secretary at Anika Therapeutics, a 18% decrease compared to previous year.

Compensation breakdown

Bonus$194,597
Option Awards$375,853
Salary$432,400
Stock Awards$375,598
Other$22,064
Total$1,400,513

Colleran received $432.4K in salary, accounting for 31% of the total pay in 2021.

Colleran also received $194.6K in bonus, $375.9K in option awards, $375.6K in stock awards and $22.1K in other compensation.

Rankings

In 2021, David Colleran's compensation ranked 7,545th out of 12,415 executives tracked by ExecPay. In other words, Colleran earned more than 39.2% of executives.

ClassificationRankingPercentile
All
7,545
out of 12,415
39th
Division
Manufacturing
3,323
out of 5,505
40th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
436
out of 801
46th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
274
out of 522
48th
Industry
Surgical and Medical Instruments and Apparatus
174
out of 327
47th
Source: SEC filing on April 27, 2022.

Colleran's colleagues

We found four more compensation records of executives who worked with David Colleran at Anika Therapeutics in 2021.

2021

Cheryl Blanchard

Anika Therapeutics

Chief Executive Officer

2021

Michael Levitz

Anika Therapeutics

Chief Financial Officer

2021

Thomas Finnerty

Anika Therapeutics

EVP, Human Resources

2021

James Loerop

Anika Therapeutics

EVP, Business Development and Strategic Planning

News

You may also like